Magazine
Latest Issue

Bipolar nation

A big shift in our understanding of mood disorders is under way, with many depressed people now being reclassified as bipolar. But is trading antidepressant drugs for mood stabilisers a sign of progress, or just the latest diagnostic fad?

Discuss this article on First Drafts, Prospect’s blog The recent Hull University report, which suggested that antidepressant drugs were no more effective than placebos for mild depression, was greeted as a welcome antidote to the age of pills. Yet missing from the media debate was an awareness of a new and fundamental shift in our understanding of mood disorders. Many of those who wrote articles lamenting their experiences on Prozac and Seroxat are, in fact, still taking psychiatric pills—but mood stabilisers rather than antidepressants. They have simply traded in one diagnosis for another. Formerly depressed, they are now officially bipolar.

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to letters@prospect-magazine.co.uk

More From Prospect